| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Zebularine | CTRPv2 | pan-cancer | AAC | 0.021 | 0.5 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | -0.027 | 0.5 |
| mRNA | Z-LLNle-CHO | GDSC1000 | pan-cancer | AAC | 0.029 | 0.5 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | -0.021 | 0.5 |
| mRNA | HG-5-113-01 | GDSC1000 | pan-cancer | AAC | -0.027 | 0.5 |
| mRNA | XMD13-2 | GDSC1000 | pan-cancer | AAC | -0.019 | 0.5 |
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | -0.021 | 0.5 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.5 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | 0.019 | 0.6 |